Recent Finacing
Recent Raise
Bright Angel Therapeutics is a Toronto preclinical biotech discovering fungal-selective small molecules that inhibit Hsp90-mediated stress responses to augment major antifungal classes and avoid human homologs using Schrödinger design.
Focus Areas
Recent Investors
Funding round
Investors
